FKBP12-calcineurin complex (FKBP12-CN)

The FKBP12-calcineurin complex is a critical signaling assembly in the immune system, primarily formed through the mediation of immunosuppressive drugs like tacrolimus [StatPearls, 2023]. FKBP12 (FK506-binding protein 12) is a prolyl isomerase that, when bound to tacrolimus, gains the ability to bind and inhibit calcineurin, a calcium-dependent serine/threonine phosphatase [UniProt P62942]. Calcineurin's primary role is the dephosphorylation of the transcription factor NFAT (Nuclear Factor of Activated T-cells), which is essential for its translocation into the nucleus and the subsequent induction of cytokine genes like IL-2 [PubMed, 1991]. By inhibiting this complex, drugs effectively block T-cell activation and proliferation, making it a cornerstone target for preventing organ transplant rejection and treating various autoimmune conditions [NIH, 2022]. However, because calcineurin is expressed in various tissues, including the kidneys and brain, systemic inhibition of this complex is associated with significant side effects such as nephrotoxicity and neurotoxicity [Journal of Clinical Investigation, 1999].

Other names

FKBP1A-calcineurin complexFK506-FKBP12-calcineurin complexTacrolimus-FKBP12-calcineurin complexImmunophilin-calcineurin complex

Tacrolimus or pimecrolimus binds to the immunophilin FKBP12 to form a drug-protein complex that sterically hinders the active site of calcineurin, preventing the dephosphorylation of Nuclear Factor of Activated T-cells (NFAT) and subsequent T-cell activation [PubChem, CID 581630].